The 2nd Amendment of IEC 60601-1 3rd Edition includes several changes and … [Read More...] about An Overview of IEC 60601-1 3rd Edition, 2nd Amendment
Main Content
White Papers
Monitoring the Pulse of Precision Medicine – 2021 Trends in Personalized Medicine
Evolving rules and technologies in precision medicine, or personalized … [Read More...] about Monitoring the Pulse of Precision Medicine – 2021 Trends in Personalized Medicine
Sponsored Content
Component Testing & Analysis: How to Gain Deeper Insights with a Universal Testing System
By Landon Goldfarb, Senior Applications Engineer, Instron Component Testing & Analysis: How to Gain Deeper Insights with a Universal Testing System Universal testing systems are most … [Read More...] about Component Testing & Analysis: How to Gain Deeper Insights with a Universal Testing System
How To Make Your Clinical Monitoring Efforts Matter
How should sponsors and sites define successful clinical monitoring today, and what can they do to ensure they achieve their goals? By John Lehmann, Director of Business Development Whether you’re … [Read More...] about How To Make Your Clinical Monitoring Efforts Matter
Mergers & Acquisitions.
Report: Permira eyeing LivaNova purchase
Private equity firm Permira has reportedly submitted a bid to acquire LivaNova (NSDQ:LIVN), which is valued at $3.7 billion. The Financial Times reported that people familiar with the situation cited an offer made in mid-February that valued London-based LivaNova’s shares at more than $80 per share. The report said talks are ongoing but there is no […]
Amgen to acquire Five Prime Therapeutics for $1.9B
Amgen (NSDQ:AMGN) announced today that it is set to acquire Five Prime Therapeutics (NSDQ:FPRX) for approximately $1.9 billion. Thousand Oaks, Calif.-based Amgen will acquire South San Francisco-based Five Prime for $38 per share in cash, reaching the equity value of approximately $1.9 billion, according to a news release. Get the full story at our sister site, Drug Delivery […]
Becton Dickinson acquires smart medication device maker GSL Solutions
Becton Dickinson (NYSE:BDX) announced today that it acquired smart medication device developer GSL solutions for an undisclosed amount. Franklin Lakes, N.J.-based BD said in a news release that GSL Solutions develops devices for storing and tracking controlled substances, as well as patient-specific medications that improve the security, efficiency and compliance of medication storage. Additionally, the company […]
Hillrom execs change their minds on BardyDx acquisition
Hillrom (NYSE:HRC) says closing conditions have not been met when it comes to the company’s previously planned $375 million acquisition of Bardy Diagnostics and its Carnation Ambulatory Monitor, or CAM patch. In response, BardyDx has sued Hillrom in the Delaware Court of Chancery, asking the court to order the merger to proceed because Hillrom’s argument […]
Boston Scientific to acquire Lumenis surgical business for $1.07B
Boston Scientific (NYSE:BSX) announced today that it entered into a definitive agreement to acquire the global surgical business of Lumenis for nearly $1.1 billion. Marlborough, Mass.–based Boston Scientific, entered into the agreement with an affiliate of Baring Private Equity Asia (BPEA) to acquire the privately-held company’s global surgical business, which develops and commercializes energy-based medical […]
Varian CEO Dow Wilson to retire after merger with Siemens Healthineers
Varian (NYSE: VAR) announced today that CEO Dow Wilson will retire after Siemens Healthineers‘ planned $16.4 billion acquisition of the company, which is expected to close in the first half of this year. Wilson, who has been with Varian for 16 years, will serve as a special advisor to Siemens Healthineers (Frankfurt: SHL) to help […]
Boston Scientific completes Preventice buy, divests BTG Pharmaceutical business
Boston Scientific (NYSE:BSX) announced that it completed its acquisition of Preventice Solutions that could be worth up to $1.225 billion. The transaction includes a cash payment of $925 million upfront with up to an additional $300 million in potential commercial milestone payments available. Accounting for the company’s approximately 22% equity stake in Preventice prior to the […]
